Skip to main content
. 2018 Jul 28;18:353. doi: 10.1186/s12879-018-3220-8

Fig. 1.

Fig. 1

Symptom prevalence by FLU-PRO domains and total scores of symptomatic participants. Proportion of symptomatic participants by FLU-PRO domains and total scores prior to inoculation, Day 3, and Day 10. By Day 3, more participants reported symptoms in all domains and total score compared to baseline with near resolution to baseline prevalence by Day 10